Dr. Alexandra Medoro shares how CHOP’s Congenital and Perinatal Infections Clinic supports infants and families through expert care, follow-up and education.

Understanding how the parasites operate gives important insight into drug development for needed novel therapies

Risk of transmission of the rotavirus vaccine is extremely low and poses very minimal risk to NICU babies

Learn why whooping cough (pertussis) is making a comeback, what symptoms are, and how to protect your family.

The vaccine is the first mRNA vaccine against C. difficile and would be the first vaccine in general to successfully ward off the bacterial infection.

Vaccination associated with moderate protection in large, diverse cohort.

As a research trainee in infectious diseases, Dr. Molnar studies metabolic regulators to develop promising antimalarial therapies. Follow a day in her life.

CHOP researchers have shown that IgA acts as a “tuner” that regulates the number of microbes the body sees every day, restraining a systemic immune response.

Since infants rely on antibodies passed from mother to baby during pregnancy, the findings suggest a need for alternative strategies for boosting infant immunity in the event of an outbreak.

As mask mandates are lifting across the U.S., many are asking what kids under 5 should do. A CHOP infectious disease expert shares guidance with several news media outlets.